Bactiguard Overview

  • Year Founded
  • 2005

Year Founded

  • Status
  • Public

  • Employees
  • 196

Employees

  • Stock Symbol
  • BACTI B

Stock Symbol

  • Investments
  • 2

  • Share Price
  • $7.29
  • (As of Thursday Closing)

Bactiguard General Information

Description

Bactiguard Holding AB is a medical device company. It is engaged in the development of infection prevention solutions, which reduce the risk of infections and the use of antibiotics. Its technology is based on the Bactiguard Infection Protection (BIP), a thin coating permanently bound to the surface of medical devices. Its portfolio contains urinary catheters, endotracheal tubes, central venous catheters, Hydrocyn for disinfection and wound care, as well as sutures and other wound care products. Its geographical segments are United States, Sweden, Malaysia, China, Thailand, Bangladesh, New Zeeland, and Other countries.

Contact Information

Ownership Status
Publicly Held
Financing Status
Formerly VC-backed
Primary Industry
Therapeutic Devices
Other Industries
Medical Supplies
Stock Exchange
STO
Corporate Office
  • 2nd Floor, Vasagatan 11
  • 111 20 Stockholm
  • Sweden
+46 08-440 00 00

Want detailed data on 3M+ companies?

What you see here scratches the surface

Request a free trial

Want to dig into this profile?

We’ll help you find what you need

Learn more

Bactiguard Stock Performance

(As of Thursday Closing)

Stock Price Previous Close 52 wk Range Market Cap Shares Average Volume EPS
$7.29 $6.57 $4.48 - $9.12 $256M 35M 11.9K -$0.34

Bactiguard Financials Summary

In Thousands,
USD
TTM 31-Mar-2024 FY 2023 31-Dec-2023 FY 2022 31-Dec-2022 FY 2021 31-Dec-2021
EV 247,014 226,905 372,973 640,436
Revenue 19,011 19,192 22,348 19,736
EBITDA (9,504) (8,491) (49) (358)
Net Income (11,898) (13,019) (5,212) (6,844)
Total Assets 62,533 66,258 77,427 93,846
Total Debt 22,562 23,324 22,882 27,399
Public Fundamental Data provided by Morningstar, Inc. disclaimer

Bactiguard Valuation & Funding

Deal Type Date Amount Valuation/
EBITDA
Post-Val Status Debt

This information is available in the PitchBook Platform. To explore Bactiguard‘s full profile, request access.

Request a free trial

Bactiguard Comparisons

Description
Primary
Industry
HQ Location
Employees
Total Raised
Post Valuation
Last
Financing
Details
Bactiguard Holding AB is a medical device company. It is engaged in the development of infection prevention solutions, w
Therapeutic Devices
Stockholm, Sweden
196 As of 2024
00000
00000 0000-00-00
000000000 00000

000000

enim ad minim veniam, quis nostrud exercitation ullamco laboris nisi ut aliquip
00000000000 0000000
Marlborough, MA
00000 As of 0000
00.00
000000000 00 00.00

000000

aboris nisi ut aliquip ex ea commodo consequat. Duis aute irure dolor in reprehe
00000000000 0000000
Irvine, CA
000 As of 0000
00000
0000000000.
Add Comparison

PitchBook’s comparison feature gives you a side-by-side look at key metrics for similar companies. Personalize which data points you want to see and create visualizations instantly.

Request a free trial

Bactiguard Competitors (12)

Company Name Financing Status Location Employees Total Raised Last Financing Date/Type Last Financing Amount
Boston Scientific Corporation Marlborough, MA 00000 00.00 000000000 00 00.00
Endologix Corporation Irvine, CA 000 00000 0000000000.
Bausch & Lomb-Iom Corporation Vimodrone, Italy 000
Cordis Private Equity-Backed Miami Lakes, FL 0000 00.000 000000000 00.000
Alvimedica Corporation Istanbul, Turkey
You’re viewing 5 of 12 competitors. Get the full list »

Bactiguard Patents

Bactiguard Recent Patent Activity

Publication ID Patent Title Status First Filing Date Technology (CPC) Citations
EP-4281599-A1 Silver free surface coating Pending 12-Apr-2022 000000000
CA-3208238-A1 Electro-activated super oxidized water and method of synthesizing the same Pending 12-Mar-2021 00000000
AU-2019258157-A1 Use of a substrate coating for decreasing leakage of matter Active 25-Apr-2018 00000000
US-20210238427-A1 Use of a substrate coating for decreasing leakage of matter Active 25-Apr-2018 0000000000 0
EP-3784302-B1 Use of a substrate coating for decreasing leakage of matter Active 25-Apr-2018 A61L31/088
To view Bactiguard’s complete patent history, request access »

Bactiguard Executive Team (17)

Name Title Board Seat Contact Info
Thomas von Koch Chief Executive Officer & Board Member
Christine Lind Chief Executive Officer
Patrick Bach Chief Financial Officer, Finance
Sathish Subramaniam Chief Technology Officer
Carl Fredin Chief Licensing and Marketing Officer
You’re viewing 5 of 17 executive team members. Get the full list »

Bactiguard Board Members (5)

Name Representing Role Since
Christian Kinch Bactiguard Chairman & Board Member 000 0000
Magdalena Persson Bactiguard Board Member 000 0000
Richard Kuntz MD Self Board Member 000 0000
Thomas von Koch Bactiguard Chief Executive Officer & Board Member 000 0000
You’re viewing 4 of 5 board members. Get the full list »

Bactiguard Signals

Growth Rate

0.80% Weekly
Growth
Weekly Growth 0.80%, 93rd %
-35.5%. 530%

Size Multiple

219x Median
Size Multiple 219x, 100th %ile
0.00x 0.95x. 413Kx

Key Data Points

Twitter Followers

5.5k

Similarweb Unique Visitors

15.0K

Majestic Referring Domains

314

PitchBook’s non-financial metrics help you gauge a company’s traction and growth using web presence and social reach.

Request a free trial

Bactiguard Investors

Investor Name Investor Type Holding Investor Since Participating Rounds Contact Info

This information is available in the PitchBook Platform. To explore Bactiguard‘s full profile, request access.

Request a free trial

Bactiguard Investments & Acquisitions (2)

Company Name Deal Date Deal Type Deal Size Industry Lead Partner
Teint 18-Apr-2023 00000 0000 00000 Medical Supplies
Vigilenz Medical Devices 28-Feb-2020 Merger/Acquisition 00.000 Medical Supplies 000000000
To view Bactiguard’s complete investments and acquisitions history, request access »

Bactiguard ESG

Risk Overview

Risk Rating

Updated December, 06, 2022

19.16 | Low Risk

Risk Scale

A lower score indicates better sustainability

Negl

0-10

Low

10-20

Med

20-30

High

30-40

Severe

40+

Exposure

Exposure refers to the extent to which a company is exposed to different material ESG issues

00.00

Management

Management is related to actions taken to manage ESG issues

00.00

Peers Analysis

Peer performance insights compare the company’s ESG performance to the performance of selected peers to help inform future ESG decisions and drive internal performance improvements.

Global

Covered Companies

00 of 16,191

Rank

00.00

Percentile

Healthcare

Industry

00 of 643

Rank

00.00

Percentile

Medical Supplies

Subindustry

00 of 58

Rank

00.00

Percentile

To view Bactiguard’s complete esg history, request access »

Bactiguard FAQs

  • When was Bactiguard founded?

    Bactiguard was founded in 2005.

  • Who is the founder of Bactiguard?

    Thomas von Koch is the founder of Bactiguard.

  • Who is the CEO of Bactiguard?

    Thomas von Koch and Christine Lind are the CEOs of Bactiguard.

  • Where is Bactiguard headquartered?

    Bactiguard is headquartered in Stockholm, Sweden.

  • What is the size of Bactiguard?

    Bactiguard has 196 total employees.

  • What industry is Bactiguard in?

    Bactiguard’s primary industry is Therapeutic Devices.

  • Is Bactiguard a private or public company?

    Bactiguard is a Public company.

  • What is Bactiguard’s stock symbol?

    The ticker symbol for Bactiguard is BACTI B.

  • What is the current stock price of Bactiguard?

    As of 20-Jun-2024 the stock price of Bactiguard is $7.29.

  • What is the current market cap of Bactiguard?

    The current market capitalization of Bactiguard is $256M.

  • What is Bactiguard’s current revenue?

    The trailing twelve month revenue for Bactiguard is $19M.

  • Who are Bactiguard’s competitors?

    Boston Scientific, Endologix, Bausch & Lomb-Iom, Cordis, and Alvimedica are some of the 12 competitors of Bactiguard.

  • What is Bactiguard’s annual earnings per share (EPS)?

    Bactiguard’s EPS for 12 months was -$0.34.

Data Transparency

  • Meet our data hygiene team

    Discover how our experts ensure you’re getting the most accurate financial data in the industry.

    Read blog »
  • How PitchBook sources data

    Our data operations team has logged over 3.5 million hours researching, organizing, and integrating the information you need most.

    Discover our process »